Two hormone drugs go head-to-head in uterine cancer trial before surgery
NCT ID NCT07436793
Summary
This study compares two hormone treatments given before surgery for endometrial cancer or precancerous uterine growths. Researchers want to see which drug works better at slowing cancer cell growth in the uterus before it's removed. About 140 women will take either megestrol acetate or micronized progesterone pills for 3 weeks before their standard surgery. The goal is to find the most effective hormone therapy to control the disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENDOMETRIAL ENDOMETRIOID ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Iowa/Holden Comprehensive Cancer Center
Iowa City, Iowa, 52242, United States
Contact Email: •••••@•••••
Contact
-
University of New Mexico Cancer Center
Albuquerque, New Mexico, 87106, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University of Utah Sugarhouse Health Center
Salt Lake City, Utah, 84106, United States
Contact Email: •••••@•••••
Contact
-
University of Virginia Cancer Center
Charlottesville, Virginia, 22908, United States
Contact Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.